For Patients & Caregivers

Hops extracts have not been shown to have anticancer effects in humans.

Hops are traditionally used in beer brewing as flavoring agents. Studies done in laboratory and in animals have shown that hops extract has anticancer effects. It has not been studied in cancer patients. Human studies with hops indicate benefits for patients with type-2 diabetes, osteoarthritis, and insomnia. Hops extracts have been used to reduce hot flashes in menopausal women. Because they have estrogenic effects, women with hormone-sensitive cancers should avoid hops.

  • Arthritis
    When used in combination with rosemary leaf and oleanolic acid, hops extract reduced pain in patients with osteoarthritis. More studies are needed.
  • Sleeping aid
    When used in combination with valerian, hops extracts improved sleep in patients with mild insomnia. More data are needed.
  • Menopausal symptoms
    Hops extract decreased hot flashes in menopausal women but further studies are warranted.
  • Diabetes
    In a small study, hops extract lowered blood glucose and improved insulin sensitivity in patients with type-2 diabetes. Larger studies are required to confirm such effects.
  • You have hormone-sensitive cancer.
Back to top

For Healthcare Professionals

Humulus lupulus L.

Hops are the female inflorescences of the plant Humulus lupulus L. They are used primarily in beer brewing to add bitterness and flavor. Hops is also used as an herbal medicine for mood disturbance and insomnia (1) and to treat menopausal symptoms. In vitro studies have shown that hops has chemopreventive (2)(3)(4) antitumor (5), antiangiogenic (6), anti-inflammatory (19) and antidiabetic (7) properties. Hops also reduces hyperlipidemia (8) and obesity (9) in mice.

In human studies, a hops-valerian combination product improved sleep quality (10) (16), and insulin sensitivity in patients with type-2 diabetes (7). Data from an observational study suggest benefits of a combination of hops, rosemary extract and oleanolic acid in reducing arthritic pain (11). However, it is not clear whether hops alone would exert similar effects.

A hops extract was shown to alleviate menopausal symptoms (13) (17), and may improve bone health (18) in postmenopausal women. Some studies also indicate that derivates of hops have phytoestrogenic effects (7) (12). Until more research is done, patients with hormone-sensitive cancers should avoid it.

Female inflorescences of Humulus lupulus L.

  • Arthritis
  • Fibromyalgia
  • Insomnia
  • Menopausal symptoms
  • Diabetes

Isomerized hops extracts (IHEs) increase plasma HDL levels and decrease atherosclerosis index (AI) in mice on high fat, high cholesterol diet via PPAR-alpha activation (14). These extracts also reduced plasma triglyceride levels and induced hepatomegaly (8). Other studies show IHE rich in isohumulone can inhibit PGE2 production and reduce the formation aberrant crypt foci in the colon of mice. Xanthohumol, a flavonoid from hop exhibits antiangiogenic effect by inhibiting the NF-kB and Akt pathway (6). A product containing hops extract reduces levels of C-reactive protein in patients with inflammatory diseases (12).

Prenyl flavonoids from hops, xanthohumol, isoxanthohumol, and 8-prenylnaringen (8-PN) inhibit aromatase activity and breast cancer cell proliferation, and increase breast cancer cell apoptosis in vitro (5). They also inhibit prostate cancer cell proliferation in vitro (3). However, isoxanthohumols are converted in the distal human gut into the phytoestrogen 8-prenylnaringen (8-PN) via the action of intestinal microflora (12). This process also occurs in the liver and is regulated by the cytochrome P450 enzymes (15).

Patients with hormone-sensitive cancer should avoid hops extracts due to their phytoestrogenic effects (7) (12).

  • Cytochrome P450 substrates:  Drugs that induce CYP1A2 may increase the estrogenic effect of hops extracts (15).
  • Paracetamol: Some hops species may slow clearance of paracetamol, thereby increasing its analgesic effects  (20).
  • Isomerized hops extracts (IHEs) may increase plasma HDL levels (14).
  • Hops extract in combination with rosemary extract and oleanolic acid may reduce C-reactive protein in patients presenting with elevated levels (11).
  1. Piersen CE. Phytoestrogens in botanical dietary supplements: implications for cancer. Integr Cancer Ther. Jun 2003;2(2):120-138.
  2. Dietz BM, Kang YH, Liu G, et al. Xanthohumol isolated from Humulus lupulus Inhibits menadione-induced DNA damage through induction of quinone reductase. Chem Res Toxicol. Aug 2005;18(8):1296-1305.
  3. Delmulle L, Bellahcene A, Dhooge W, et al. Anti-proliferative properties of prenylated flavonoids from hops (Humulus lupulus L.) in human prostate cancer cell lines. Phytomedicine. Nov 2006;13(9-10):732-734.
  4. Nozawa H, Nakao W, Zhao F, Kondo K. Dietary supplement of isohumulones inhibits the formation of aberrant crypt foci with a concomitant decrease in prostaglandin E2 level in rat colon. Mol Nutr Food Res. Aug 2005;49(8):772-778.
  5. Monteiro R, Faria A, Azevedo I, Calhau C. Modulation of breast cancer cell survival by aromatase inhibiting hop (Humulus lupulus L.) flavonoids. J Steroid Biochem Mol Biol. Jun-Jul 2007;105(1-5):124-130.
  6. Albini A, Dell’Eva R, Vene R, et al. Mechanisms of the antiangiogenic activity by the hop flavonoid xanthohumol: NF-kappaB and Akt as targets. FASEB J. Mar 2006;20(3):527-529.
  7. Yajima H, Ikeshima E, Shiraki M, et al. Isohumulones, bitter acids derived from hops, activate both peroxisome proliferator-activated receptor alpha and gamma and reduce insulin resistance. J Biol Chem. Aug 6 2004;279(32):33456-33462.
  8. Shimura M, Hasumi A, Minato T, et al. Isohumulones modulate blood lipid status through the activation of PPAR alpha. Biochim Biophys Acta. Sep 5 2005;1736(1):51-60.
  9. Yajima H, Noguchi T, Ikeshima E, et al. Prevention of diet-induced obesity by dietary isomerized hop extract containing isohumulones, in rodents. Int J Obes (Lond). Aug 2005;29(8):991-997.
  10. Morin CM, Koetter U, Bastien C, Ware JC, Wooten V. Valerian-hops combination and diphenhydramine for treating insomnia: a randomized placebo-controlled clinical trial.Sleep. Nov 1 2005;28(11):1465-1471.
  11. Lukaczer D, Darland G, Tripp M, et al. A pilot trial evaluating Meta050, a proprietary combination of reduced iso-alpha acids, rosemary extract and oleanolic acid in patients with arthritis and fibromyalgia. Phytother Res. Oct 2005;19(10):864-869.
  12. Possemiers S, Bolca S, Grootaert C, et al. The prenylflavonoid isoxanthohumol from hops (Humulus lupulus L.) is activated into the potent phytoestrogen 8-prenylnaringenin in vitro and in the human intestine. J Nutr. Jul 2006;136(7):1862-1867.
  13. Heyerick A, Vervarcke S, Depypere H, Bracke M, De Keukeleire D. A first prospective, randomized, double-blind, placebo-controlled study on the use of a standardized hop extract to alleviate menopausal discomforts. Maturitas. May 20 2006;54(2):164-175.
  14. Miura Y, Hosono M, Oyamada C, Odai H, Oikawa S, Kondo K. Dietary isohumulones, the bitter components of beer, raise plasma HDL-cholesterol levels and reduce liver cholesterol and triacylglycerol contents similar to PPARalpha activations in C57BL/6 mice. Br J Nutr. Apr 2005;93(4):559-567.
  15. Guo J, Nikolic D, Chadwick LR, Pauli GF, van Breemen RB. Identification of human hepatic cytochrome P450 enzymes involved in the metabolism of 8-prenylnaringenin and isoxanthohumol from hops (Humulus lupulus L.). Drug Metab Dispos. Jul 2006;34(7):1152-1159.
  16. Dimpfel W, Suter A. Sleep improving effects of a single dose administration of a valerian/hops fluid extract - a double blind, randomized, placebo-controlled sleep-EEG study in a parallel design using electrohypnograms. Eur J Med Res. 2008 May 26;13(5):200-4.
  17. Erkkola R, Vervarcke S, Vansteelandt S, et al. A randomized, double-blind, placebo-controlled, cross-over pilot study on the use of a standardized hop extract to alleviate menopausal discomforts. Phytomedicine. 2010 May;17(6):389-96.
  18. Holick MF, Lamb JJ, Lerman RH,et al. Hop rho iso-alpha acids, berberine, vitamin D3 and vitamin K1 favorably impact biomarkers of bone turnover in postmenopausal women in a 14-week trial. J Bone Miner Metab. 2010 May;28(3):342-50.
  19. Akazawa H, Kohno H, Tokuda H, et al. Anti-inflammatory and anti-tumor-promoting effects of 5-deprenyllupulonol C and other compounds from Hop (Humulus lupulus L.). Chem Biodivers. 2012 Jun;9(6):1045-54.
  20. Jakovljevic V, Popovic M, Raskovic A, et al. Effect of aroma and magnum hops extracts and paracetamol on antioxidant liver parameters in mice. Eur J Drug Metab Pharmacokinet. 2009 Jan-Mar;34(1):37-41.
Back to top
Back to top
Email your questions and comments to aboutherbs@mskcc.org.

Last Updated